The Biohaven 202 Study is a 12-month migraine study of an investigational medication that is taken as needed for migraine headache in the form of a nasal spray.
You may qualify to participate if you:
- Are at least 18 years of age
- Experience migraines, and:
- have 2 to 8 migraine headaches per month
- and treat at least 2 migraine headaches per month with medication
For more information, call or text Dr. Counihan at 617-875-096 or email him at: email@example.com.